InsiderSignal.AI

InsiderSignal.ai

ELV - Elevance Health, Inc.

Insider Purchase by Collis Steven H (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Collis Steven H, serving as Dir at Elevance Health, Inc. (ELV), purchased 3,000 shares at $289.84 per share, for a total transaction value of $869,520.00. Following this transaction, Collis Steven H now holds 3,639 shares of ELV.

This purchase represents a 469.00% increase in Collis Steven H's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 6, 2026, 1 day after the trade was made.

Elevance Health, Inc. operates in the HEALTHCARE sector, specifically within the HEALTHCARE PLANS industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Collis Steven H

Collis Steven H

Dir

Steven H. Collis (born 1961 or 1962, age ~64) is an accomplished healthcare executive serving as an independent Director at Elevance Health, Inc. (ELV) since August 1, 2025, with appointments to the Audit and Finance Committees and designation as an SEC “audit committee financial expert.”[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)[[2]](https://www.elevancehealth.com/newsroom/elevance-health-board-welcomes-steve-collis-as-new-director) He holds the position of Executive Chairman of Cencora, Inc. (formerly AmerisourceBergen, NYSE: COR), a role he assumed in October 2024 after serving as Chairman, President, and CEO from 2016 to September 2024, and President and CEO from 2011 to 2016.[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)[[3]](https://www.healthevolution.com/bios/speaker/steve-collis/) Collis joined AmerisourceBergen in 1994 as President of the Specialty Group, building it into a market-leading specialty pharmaceutical distribution platform.[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)[[3]](https://www.healthevolution.com/bios/speaker/steve-collis/)[[6]](https://www.ifpwfoundation.org/collis.htm) Under his leadership, the company executed key acquisitions like World Courier (2012), MWI Veterinary Supply (2015), and Alliance Healthcare (2021), alongside a strategic partnership with Walgreens Boots Alliance (2013), driving global expansion and innovation.[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)[[3]](https://www.healthevolution.com/bios/speaker/steve-collis/) He earned a Bachelor of Commerce (Honors) from the University of the Witwatersrand and serves on boards including the International Federation of Pharmaceutical Wholesalers and American Red Cross.[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)[[3]](https://www.healthevolution.com/bios/speaker/steve-collis/) Collis is independent under NYSE/SEC standards with no disclosed related-party conflicts at Elevance Health.[[1]](https://fintool.com/app/research/companies/ELV/people/steven-collis)

View full insider profile →

Trade Price

$289.84

Quantity

3,000

Total Value

$869,520.00

Shares Owned

3,639

Trade Date

Thursday, March 5, 2026

11 days ago

SEC Filing Date

Friday, March 6, 2026

Filed 1 day after trade

HEALTHCAREHEALTHCARE PLANS

About Elevance Health, Inc.

Company Overview

No company information available
View news mentioning ELV

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4543051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime